Literature DB >> 35990026

A Treatable Cause of Myelopathy: Biotinidase Deficiency Presenting as Acute Flaccid Paralysis.

Vykuntaraju K Gowda1, Chetan Kerur2, Dhananjaya K Vamyanmane3, Pragalatha Kumar2, Vani H Nagarajappa2, Sanjay K Shivappa2.   

Abstract

Biotinidase deficiency (BD) is a rare treatable cause of neurometabolic disorders. It is an autosomal recessive disorder that manifests with cutaneous and neurological manifestations. Spinal cord involvement is uncommon with only a few cases reported in the literature. A 6-year-old female child presented with progressive difficulty in walking since 2 months. At 6 months of age, the child was elsewhere evaluated for global developmental delay and suspected as metabolic disorders and started on megavitamins, following which the child was improved. For the past 2 years, she has stopped medicines. On examination, irritable, alopecia, eczema, hypotonia, and power of two-fifths in all four limbs, and exaggerated deep tendon reflexes. The magnetic resonance imaging (MRI) brain and spine showed T2/fluid-attenuated inversion recovery (FLAIR) hyperintensities in periaqueductal gray matter, dorsal midbrain, pons, medulla, and cervical cord. She was suspected to have BD and confirmed by low enzyme levels and pathogenic variant in BTD . She was started on biotin supplements that resulted clinically dramatic improvement and MRI became normal within 4 weeks. Any child presenting with acute flaccid paralysis with brainstem and spinal cord noncompressive lesions on MRI, rare treatable conditions like BD should be considered in developing countries, like India, where still no universal newborn screening facilities are available. Thieme. All rights reserved.

Entities:  

Keywords:  acute flaccid paralysis; biotinidase deficiency; demyelination; inborn errors of metabolism; spinal cord

Year:  2020        PMID: 35990026      PMCID: PMC9385254          DOI: 10.1055/s-0040-1718537

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  10 in total

1.  Biotinidase deficiency.

Authors:  Rps Tomar; D Vashisth; R Vasudevan
Journal:  Med J Armed Forces India       Date:  2012-01-18

2.  Biotinidase deficiency: a survey of 10 cases.

Authors:  H J Wastell; K Bartlett; G Dale; A Shein
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 3.  Biotinidase deficiency presenting as recurrent myelopathy in a 7-year-old boy and a review of the literature.

Authors:  Sarbani Raha; Vrajesh Udani
Journal:  Pediatr Neurol       Date:  2011-10       Impact factor: 3.372

4.  Biotinidase deficiency with hypertonia as unusual feature.

Authors:  Narendra Rathi; Manisha Rathi
Journal:  Indian Pediatr       Date:  2009-01       Impact factor: 1.411

5.  Biotinidase deficiency: clinical and MRI findings consistent with myelopathy.

Authors:  Max Wiznitzer; Barbara A Bangert
Journal:  Pediatr Neurol       Date:  2003-07       Impact factor: 3.372

6.  A boy with spastic paraparesis and dyspnea.

Authors:  H Serap Kalkanoğlu; Ali Dursun; Ayşegül Tokatli; Turgay Coşkun; Defne Karasimav; Haluk Topaloğlu
Journal:  J Child Neurol       Date:  2004-05       Impact factor: 1.987

7.  Spinal cord demyelination associated with biotinidase deficiency in 3 Chinese patients.

Authors:  Yanling Yang; Chaoyang Li; Zhaoyue Qi; Jiangxi Xiao; Yao Zhang; Seiji Yamaguchi; Yuki Hasegawa; Yasuko Tagami; Yuwu Jiang; Hui Xiong; Yuehua Zhang; Jiong Qin; Xi-Ru Wu
Journal:  J Child Neurol       Date:  2007-02       Impact factor: 1.987

8.  Neuropathology of biotinidase deficiency.

Authors:  M Honavar; I Janota; B G Neville; R A Chalmers
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Biotinidase deficiency: initial clinical features and rapid diagnosis.

Authors:  B Wolf; G S Heard; K A Weissbecker; J R McVoy; R E Grier; R T Leshner
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

10.  Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients.

Authors:  Taciane Borsatto; Fernanda Sperb-Ludwig; Louise L C Pinto; Gisele R De Luca; Francisca L Carvalho; Carolina F M De Souza; Paula F V De Medeiros; Charles M Lourenço; Reinaldo Lo Filho; Eurico C Neto; Pricila Bernardi; Sandra Leistner-Segal; Ida V Schwartz
Journal:  BMC Med Genet       Date:  2014-09-01       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.